Mitigating Recurrence Risk: A Multisite QI Initiative to Improve Clinical Outcomes and Management in Patients With High-Risk HR+/HER2- EBC

This educational program aims to enhance the knowledge, competence, and confidence of healthcare professionals in assessing and managing high-risk HR+/HER2- EBC by focusing on ways to effectively communicate risk assessment to patients and measures to implement optimal therapeutic strategies to reduce recurrence risk and optimize treatment outcomes.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC, in partnership with Q Synthesis and The American Society of Breast Surgeons Foundation

Supporters

Supported by an educational grant from Lilly.

Lilly

Partners

Q Synthesis LLC

ProCE Banner

The American Society of Breast Surgeons Foundation

ProCE Banner